Patent Assignment
Reel/Frame 053852/0697
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276
Recorded: 2020-09-22
Pages: 20
Assignor
BANK OF MONTREAL, AS COLLATERAL AGENT
Executed: 2020-09-22
Assignees
ADARE PHARMACEUTICALS, INC.
1200 LENOX DRIVE, SUITE 100, PRINCETON PIKE CORPORATE CENTER, LAWRENCEVILLE, NEW JERSEY, 08648
ADARE DEVELOPMENT I, L.P.
1200 LENOX DRIVE, SUITE 100, PRINCETON PIKE CORPORATE CENTER, LAWRENCEVILLE, NEW JERSEY, 08648
ADARE PHARMACEUTICALS USA, INC.
1200 LENOX DRIVE, SUITE 100, PRINCETON PIKE CORPORATE CENTER, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Properties
(69)
Procedure for Encapsulating Chlorpheniramine
Patent:
5,622,723 →
Application:
08/383,033 →
Effervescent Microcapsules
Patent:
5,639,475 →
Application:
08/383,342 →
Taste-Masked Microcapsule Compositions and Methods of Manufacture
Patent:
6,139,865 →
Application:
08/942,094 →
Functional Coating of Linezolid Microcapsules for Taste-Masking and Associated Formulation for Oral Administration
Patent:
6,451,345 →
Application:
09/506,051 →
Timed Pulsatile Drug Delivery Systems
Timed, Sustained Release Systems for Propranolol
Patent:
6,500,454 →
Application:
09/971,167 →
Pulsatile Release Histamine H2 Antagonist Dosage Form
Extended Release Dosage Forms of Propranolol Hydrochloride
Timed, sustained release systems for propranolol
Controlled drug release composition resistant to in vivo mechanic stress
Application:
10/556,734 →
Publication:
US 2007/0009596
Controlled Release Potassium Chloride Tablets
Timed Pulsatile Drug Delivery Systems
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Orally disintegrating tablets and methods of manufacture
Timed, pulsatile release systems
Taste-masked pharmaceutical compositions prepared by coacervation
Application:
11/213,266 →
Publication:
US 2006/0105038
Orally disintegrating tablets of atomoxetine
Taste-Masked Pharmaceutical Compositions
Taste-Masked Pharmaceutical Compositions with Gastrosoluble Pore-Formers
Application:
11/256,653 →
Publication:
US 2006/0105039
Timed, Sustained Release Systems for Propranolol
Drug Delivery Systems Comprising Weakly Basic Selective Serotonin 5-HT3 Blocking Agent and Organic Acids
Application:
11/668,167 →
Publication:
US 2007/0190145
Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids
Application:
11/668,408 →
Publication:
US 2007/0196491
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Pharmaceutical Compositions Comprising an Active Substance from the Substituted Benzhydrylpiperazine Family
Orally Disintegrating Tablet Compositions of Lamotrigine
Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Orally Disintegrating Tablet Compositions of Temazepam
Application:
12/339,908 →
Publication:
US 2009/0169620
Compositions Comprising Weakly Basic Drugs and Controlled-Release Dosage Forms
Application:
12/424,201 →
Publication:
US 2009/0258066
Taste-Masked Pharmaceutical Compositions Prepared by Coacervation
Application:
12/466,855 →
Publication:
US 2009/0263480
Preparation of Controlled Release Skeletal Muscle Relaxant Dosage Forms
Orally Disintegrating Tablet Compositions of Lamotrigine
Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
Application:
12/772,770 →
Publication:
US 2010/0330150
Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics
Orally Administered Corticosteroid Compositions
Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture
Application:
12/956,543 →
Publication:
US 2011/0129530
Timed, Pulsatile Release Systems
Controlled Release Compositions Comprising Anti-Cholinergic Drugs
Application:
13/202,957 →
Publication:
US 2011/0311626
Controlled-Release Compositions Comprising a Proton Pump Inhibitor
Application:
13/202,959 →
Publication:
US 2012/0128764
Rapidly Dispersing Granules, Orally Disintegrating Tablets and Methods
Application:
13/310,632 →
Publication:
US 2012/0282335
Preparation of Controlled Release Skeletal Muscle Relaxant Dosage Forms
Application:
13/371,967 →
Publication:
US 2012/0196028
Orally Disintegrating Tablet Compositions of Lamotrigine
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Drug Delivery Systems Comprising Solid Solutions of Weakly Basic Drugs
Orally Disintegrating Tablets and Methods of Manufacture
Rapid Dissolve Tablet Compositions for Vaginal Administration
Application:
14/069,712 →
Publication:
US 2014/0134246
Orally Disintegrating Tablet Compositions of Lamotrigine
Orally Administered Corticosteroid Compositions
Sustained Release Particle Formulations
Orally Administered Corticosteroid Compositions
Stablized Modified Release Folic Acid Derivative Composition, Its Therapeutic Use and Methods of Manufacture
Application:
14/445,949 →
Publication:
US 2015/0030676
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
Orally Administered Corticosteroid Compositions
Taste Masking Drug Formulations
Extended-Release Drug Delivery Compositions
Methods of Treating Eosinophilic Esophagitis
Sustained Release Particle Formulations
Orally Administered Corticosteroid Compositions
Methods of Treating Eosinophilic Esophagitis
Biodegradable Polymer Microsphere Compositions for Parenteral Administration
Extended-Release Drug Delivery Compositions
Application:
16/359,602 →
Publication:
US 2019/0216825
Sustained Release Particle Formulations
Taste Masking Drug Formulations
Stablized Modified Release Folic Acid Derivative Composition, Its Therapeutic Use and Methods of Manufacture
Application:
61/859,627 →
Methods of Managing Eosinophilic Esophagitis
Application:
62/633,432 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Aug 30, 2012
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 028884/0903 →
Change of Name
Sep 30, 2012
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 029058/0568 →
Release of Lien on Patents
Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMATECH, INC.
Reel/Frame 031494/0925 →
Patent Security Agreement
Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release
Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Change of Name
Jun 19, 2014
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH, INC.
Reel/Frame 033212/0635 →
Change of Name
Aug 5, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036283/0261 →
Change of Name
Aug 6, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036294/0319 →
Change of Name
Aug 18, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036380/0942 →
Change of Name
Aug 18, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036380/0893 →
Change of Name
Aug 18, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036380/0926 →
Assignment of Assignor's Interest
Sep 1, 2015
From: APTALIS PHARMA LIMITED
To: APTALIS PHARMATECH, INC.
Reel/Frame 036470/0586 →
Assignment of Assignor's Interest
Sep 4, 2015
From: APTALIS PHARMA LIMITED
To: APTALIS PHARMATECH, INC.
Reel/Frame 036495/0555 →
Change of Name
Sep 4, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036554/0829 →
Change of Name
Sep 4, 2015
From: EURAND PHARMACEUTICALS LTD.
To: APTALIS PHARMA LIMITED
Reel/Frame 036554/0819 →
Change of Name
Sep 15, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036627/0848 →
Change of Name
Sep 18, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036640/0591 →
Change of Name
Sep 25, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036689/0358 →
U.S. Patent Security Agreement
Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Security Interest
Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Security Interest
Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →